Related Experiment Video
Updated: Jan 7, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells
Kenta Kurayoshi1, Masakazu Tanaka2, Rinka Nakajima1
1Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda 669-1330, Hyogo, Japan.
Abstract:
The transcription factor E2F is the principal target of the tumor suppressor pRB. In almost all cancers, pRB function is disabled due to oncogenic changes, leading to enhanced E2F activity, thereby facilitating aberrant cell proliferation. Enhanced E2F activity has been utilized to drive gene expression preferentially in cancer cells using E2F target promoters, such as the E2F1 promoter. However, these promoters are also activated by physiological E2F activity in normal proliferating cells, resulting in gene expression in normal proliferating cells. In contrast, promoters of tumor suppressor genes, such ARF and TAp73, are activated by deregulated E2F activity, induced by loss of pRB control, but not by physiological E2F activity, induced by growth stimulation, thereby providing a mechanism to drive expression specifically in cancer cells. Here we show artificial promoters, in which E2F-responsive elements of the TAp73 gene are tandemly connected to the ARF core promoter, exhibited higher cancer cell specificity than E2F1, hTERT, or ARF promoters. Moreover, adenoviruses driving a cytotoxic gene using these artificial promoters showed cancer cell-specific cytotoxicity and inhibited tumor growth in a xenograft mouse model. These results indicate utility of tumor suppressor gene promoter elements to drive gene expression specifically in cancer cells.
Insights
Researchers developed novel artificial promoters using tumor suppressor gene elements. These promoters show high specificity for cancer cells, enabling targeted gene expression and cytotoxicity, and inhibiting tumor growth in mice.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- The retinoblastoma protein (pRB) normally suppresses tumors by regulating the E2F transcription factor.
- Loss of pRB function in cancer leads to uncontrolled E2F activity, promoting cell proliferation.
- Existing E2F target promoters (e.g., E2F1) lack cancer cell specificity, activating genes in normal proliferating cells.
Purpose of the Study:
- To engineer promoters with enhanced specificity for cancer cells by exploiting tumor suppressor gene regulatory elements.
- To evaluate the efficacy of these novel promoters in driving cancer-specific gene expression and therapeutic effects.
Main Methods:
- Constructed artificial promoters by linking E2F-responsive elements from the TAp73 gene to the ARF core promoter.
- Compared the cancer cell specificity of these artificial promoters against known promoters (E2F1, hTERT, ARF).
- Utilized adenoviruses to deliver a cytotoxic gene under the control of the artificial promoters.
- Assessed cancer cell-specific cytotoxicity and tumor growth inhibition in a xenograft mouse model.
Main Results:
- The novel artificial promoters demonstrated superior cancer cell specificity compared to E2F1, hTERT, and ARF promoters.
- Adenoviruses employing these promoters induced cytotoxicity specifically in cancer cells.
- Significant inhibition of tumor growth was observed in vivo using the engineered adenoviral system.
Conclusions:
- Artificial promoters derived from tumor suppressor gene elements offer a mechanism for highly specific gene expression in cancer cells.
- This approach holds promise for targeted cancer gene therapy, minimizing off-target effects in normal tissues.
- The developed promoters are effective in driving cancer-specific cytotoxicity and suppressing tumor progression.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...